TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: TCR (Transient Cardiac Response)
Endpoint domain: Adverse events/effects
Primary endpoint: motor skill performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Emotional Intelligence (EI) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean score on helpfulness of rib models
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of correct answers for case-based question
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: reflux symptoms improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for procedure
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: 12-month recurrence-free survival
Endpoint domain: Mortality/survival
Primary endpoint: knowledge and cognition of legal obligations
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: patient safety competency
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Serum-trough concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fracture prevalence
Endpoint domain: Mortality/survival
Primary endpoint: Improvement of scores at one year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Age-standardized mean potassium intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prevalence of adequate potassium intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Quality of voice improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: surgery-eligible stage 1 and 2 lung cancer incidence
Endpoint domain: Mortality/survival
Primary endpoint: IGA-CHE treatment success at week 16
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achieved MDA-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achieved MDA-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk of progression
Endpoint domain: Mortality/survival
Primary endpoint: pain pressure threshold on upper trapezius
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compliance to mEHT treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Emotional and cognitive functioning
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Ever had vaginal sex
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Peer connectedness
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: ISI total score improvement
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: RSQ total score improvement
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: PSD sleep quality ratings improvement
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in values score on aggressive care scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Increased public discourse around income assistance policy reform
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Vpassive
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Arousal threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Muscle compensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: less maltreatment
Endpoint domain: Adverse events/effects
Primary endpoint: reduced endorsement of corporal punishment
Endpoint domain: Adverse events/effects
Primary endpoint: fewer child behaviour problems
Endpoint domain: Adverse events/effects
Primary endpoint: Primary decolonization success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Recurrent S aureus colonization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Bacterial sterile site infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: GSP level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: six-minute walk test (6MWT) power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: acute incomplete stent apposition at bifurcation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: PWV reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Peripheral vascular resistance decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Rate of amnestic MCI or PD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: utility-weighted modified Rankin scale score at 90 days
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: PNES frequency reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health outcomes associated with appropriate weight gain in pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in plasma PPi concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in plasma PLP concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time to request first rescue analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of rescue analgesia used
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SCI score increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean total MDAT score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean MacArthur‐Bates CDI vocabulary score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Voluntariness of consent
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Respectful doctor-patient interaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: composite bleeding outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: time to achieve effective analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MRC%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Likelihood of parents choosing the fruit drink
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Misbelief about added sugar content in fruit drinks
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: occlusion rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in platelet counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: General Self-Efficacy (GSE) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk Tendency (RPS) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Overall sleep efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of emotional and motivational disorders
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean maximum pain scores within 8 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: need for intubation and mechanical ventilation within 72 h of birth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: adverse events during the procedure
Endpoint domain: Adverse events/effects
Primary endpoint: Combined outcome of major bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Days without antibiotics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality at days 28 and 90
Endpoint domain: Mortality/survival
Primary endpoint: Activation of medial prefrontal regions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Activation of salience and extinction areas
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: PD/PK equivalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GAF functional remission
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Renal-specific outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: proportion of caregivers receiving timely EID results
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: time to results receipt
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: treatment initiation for infected infants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TWACB viral load reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: shoulder strength and stability gains
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Cumulative probability of incisional glaucoma surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Activation rate of oocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Cleavage rate of oocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Blastocyst stage achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Adjudicated stroke events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incident stroke symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Composite outcome of adjudicated stroke or incident symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Severity of disability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean extubation force
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage abdominal fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Diagnostic accuracy for pAK/BD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HBV-DNA level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Physicians' diagnostic accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-h AUC of plasma EPA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bilateral Grade 2, Grade 3, or Grade 4 ICH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Severe NDI
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Single leg stance test with open eye time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Timed up-and-go time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plantar area of the right foot
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attention/processing speed improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stable MMSE score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to pass first flatus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mtb infection measured by Mtb antigen-specific cytokine response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Pain affecting daily life
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in SNAP-IV inattention subscale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in SNAP-IV hyperactivity/impulsivity subscale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SF-36 MCS
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Functional exercise compliance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Secondary sulfonylurea failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Temperature difference for diagnosis of AA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of deep surgical site infection at 30 days
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of deep surgical site infection at 90 days
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of mild-moderate hypercapnia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Upper limb arterial occlusive pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Complete remission within 8 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Relapse rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: experimental provider fidelity of coaching implementation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: experimental parent fidelity of implementation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Right ventricular global longitudinal strain (RVGLS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Right ventricular global area strain (RVGAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in subset site plaque scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean calprotectin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance of the unimanual peg-transfer task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compliance rate
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Pulmonary function (6 min walking distance, FEV1%, FEV1/FVC%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of burst suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: End-tidal sevoflurane concentrations during induction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: End-tidal sevoflurane concentrations during maintenance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pediatric drug utilization
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reduction in periprocedural events
Endpoint domain: Mortality/survival
Primary endpoint: accident prevention behaviors
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: mean final-product performance score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CL (cognitive load)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: KOOS Pain improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resolution of intermittent locking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resolution of clicking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first AECOPD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Time to first severe AECOPD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Toxic and side effects
Endpoint domain: Adverse events/effects
Primary endpoint: school-based physical activity (PA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: moderate-to-severe CIPN
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reduction in vasopressor and inotropic support
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IMAT decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: VAT decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: PPT improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of adverse events of any grade
Endpoint domain: Adverse events/effects
Primary endpoint: Medication adherence rate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: AUC of the tomographic-biomechanical parameter (TBI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC of the TBI for detecting clinical ectasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FL prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identification of OHSS at-risk patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported sleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Fraction of time spent spontaneously breathing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Themes of negative language in encounter notes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Themes of positive language in encounter notes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of patients virologically suppressed with <100 copies/ml through 48 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duration of oxygen dependence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean duration of HDU stay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Favorable clinical response at 48-72 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Basal Metabolic Rate (BMR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Agreement between children's and parent's reports
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Hedonic hunger
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Confidence in resisting food consumption
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: improvement in positive mood
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: motivation to change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: accuracy in NRT knowledge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incremental Cost-Effectiveness Ratio (ICER) for extra healthy child
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: patients' wellbeing after hospital discharge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: KOOS pain scoring
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: staff job satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: level of stress of conscience
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: perceived person‐centredness of care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Grade 3 or 4 treatment-emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Moderate‐to‐severe pain when walking 24 h postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Recovery‐15
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Prediction accuracy for MGMT methylation status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for RA (Rotational Atherectomy)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of patients receiving EVT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Door-to-image time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Door-to-needle time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain score at 24 hours postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cycle regularity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total anterior corneal HOA improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vertical coma anterior corneal HOA improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Horizontal coma anterior corneal HOA improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AVF failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: cannulation failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes